Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing safety, tolerability, pharmacokinetics, and immunogenicity of BCX17725 in Netherton Syndrome. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Netherton Syndrome

Drugs mentioned

• BCX17725

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Netherton Syndrome | Phase 1 | Status: RECRUITING